Interleukin-6 polymorphism | Neuroquantology

Volume 20 No 12 (2022)

Interleukin-6 polymorphism

Ahmad Mohsen Anwar Ahmad; Samir Tamer Abdullah; Reem Abd El- Salam Abd EL-Azeez; Hend Mohammed Moness

DOI: 10.14704/NQ.2022.20.12.NQ77219

Abstract

Emerged coronavirus disease 2019 (COVID-19) is a pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). Disease severity is associated with elevated levels of proinflammatory cytokines, such as interleukin-6 (IL-6).

Keywords

Coronavirus disease 2019 (COVID-19), IL-6, Single nucleotide polymorphism, PCR-RFLP

Copyright © Neuroquantology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.